Formulation and optimization of duloxetine hydrochloride buccal films: in vitro and in vivo evaluation

Duloxetine hydrochloride (DH) is a serotonin–norepinephrine reuptake inhibitor (SSNRI) indicated for the treatment of depression. Duloxetine suffers from reduced oral bioavailability (≈50%) due to hepatic metabolism. This study aims to develop DH buccoadhesive films to improve its bioavailability. D...

Descripción completa

Detalles Bibliográficos
Autores principales: El Sharawy, Amr Mostafa, Shukr, Marwa Hassan, Elshafeey, Ahmed Hassen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8241170/
https://www.ncbi.nlm.nih.gov/pubmed/29172829
http://dx.doi.org/10.1080/10717544.2017.1402216

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8241170/
https://www.ncbi.nlm.nih.gov/pubmed/29172829
http://dx.doi.org/10.1080/10717544.2017.1402216

Ejemplares similares